Clinical Trial Update: Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer [Phase 3]

View source ↗

Summary

A Phase 3 study comparing S-1 plus oxaliplatin (SOX) with capecitabine plus oxaliplatin (COX) in patients with advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Samsung Medical Center | Conditions: Colorectal Cancer | Phase 3 | Status: COMPLETED